Drug Profile
Pegylated docetaxel - Nektar
Alternative Names: NKTR-105; PEG-docetaxelLatest Information Update: 18 Dec 2021
Price :
$50
*
At a glance
- Originator Nektar Therapeutics
- Class Antineoplastics; Polyethylene glycols; Radiopharmaceutical diagnostics; Small molecules; Taxanes
- Mechanism of Action Tubulin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Solid-tumours in USA (IV)
- 22 Apr 2009 Pharmacodynamics data from a preclinical study in Cancer presented at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009)
- 17 Feb 2009 Phase-I clinical trials in Solid tumours in USA (IV)